世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

心房細動デバイスの世界・米国市場レポート&予測 2022-2028


Global and United States Atrial Fibrillation Devices Market Report & Forecast 2022-2028

本レポートは、心房細動デバイス市場を調査したものです。心房細動(AFibまたはAFとも呼ばれる)は、血栓、脳卒中、心不全、その他の心臓関連の合併症を引き起こす可能性のある、震えや不整脈(不整脈)です。心... もっと見る

 

 

出版社 出版年月 電子版価格 言語
QYResearch
QYリサーチ
2022年4月15日 US$4,350
シングルユーザライセンス
ライセンス・価格情報・注文方法はこちら
英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


 

サマリー

本レポートは、心房細動デバイス市場を調査したものです。心房細動(AFibまたはAFとも呼ばれる)は、血栓、脳卒中、心不全、その他の心臓関連の合併症を引き起こす可能性のある、震えや不整脈(不整脈)です。心房細動デバイスは、心房細動治療に使用されるデバイスで、アクセス、診断、可視化、アブレーション製品などがあり、医師が様々な不整脈を診断・治療するのを支援するものです。
市場の分析と洞察心房細動デバイスの世界市場および米国市場
本レポートは、世界と米国の心房細動デバイス市場に焦点を当て、その他の地域の地域レベル、郡レベルのセグメントデータもカバーしています。
COVID-19の大流行により、心房細動デバイスの世界市場規模は2022年に3億3940万米ドル相当と推定され、2022年から2028年の予測期間中にCAGR8.6%で5億5780万米ドルの再調整サイズになると予測されています。この健康危機による経済変化を十分に考慮し、タイプ別では、2021年に心房細動デバイス世界市場の%を占めたカテーテルアブレーションが、2022年から2028年まで改訂された%のCAGRで成長し、2028年までに百万米ドルを値にすると予測されます。アプリケーション別では、病院が主要セグメントで、2021年の市場シェアは%以上を占め、この予測期間を通して%CAGRに変更されました。
心房細動デバイスの主要メーカーは、ジョンソン&ジョンソン、ボストン・サイエンティフィック、アボット、メドトロニック、日本ライフライン、アトリキュアで、上位3社で約65%を占めています。
市場規模は北米が約35%でトップ、次いで欧州が約30%となっています。
世界の心房細動デバイスの範囲と市場規模
心房細動デバイスの市場は、地域(国)別、プレイヤー別、タイプ別、アプリケーション別に分類されています。世界の心房細動デバイス市場におけるプレイヤー、ステークホルダー、その他の参加者は、本レポートを強力なリソースとして活用することで、優位に立つことが可能となるでしょう。セグメント別分析では、地域(国)別、タイプ別、アプリケーション別の収益と予測に焦点を当て、2017年から2028年までの期間を分析します。
米国市場については、2017-2028年までのプレイヤー別、タイプ別、アプリケーション別の心房細動デバイスの市場規模に焦点を当てています。主要プレイヤーには、米国で重要な役割を果たすグローバルプレイヤーやローカルプレイヤーが含まれます。
タイプ別セグメント
カテーテルアブレーション
メイズ手術
アプリケーション別セグメント
病院
外来手術センター
その他
地域別
北米
米国
カナダ
欧州
ドイツ
フランス
英国
イタリア
ロシア
アジア太平洋地域
中国
日本
韓国
インド
オーストラリア
台湾
インドネシア
タイ
マレーシア
フィリピン
ベトナム
中南米
メキシコ
ブラジル
アルゼンチン
中東・アフリカ
トルコ
サウジアラビア
U.A.E
会社別
ジョンソン・エンド・ジョンソン
アボット
メドトロニック
日本ライフライン
ボストン・サイエンティフィック
アトリキュア
ビオトロニック
オシプカ
カーディオフォーカス
マイクロポートEPメドテック
シナプティックメディカル


ページTOPに戻る


目次

1 Study Coverage
1.1 Atrial Fibrillation Devices Product Introduction
1.2 Global Atrial Fibrillation Devices Outlook 2017 VS 2022 VS 2028
1.2.1 Global Atrial Fibrillation Devices Sales in US$ Million for the Year 2017-2028
1.2.2 Global Atrial Fibrillation Devices Sales in Volume for the Year 2017-2028
1.3 United States Atrial Fibrillation Devices Outlook 2017 VS 2022 VS 2028
1.3.1 United States Atrial Fibrillation Devices Sales in US$ Million for the Year 2017-2028
1.3.2 United States Atrial Fibrillation Devices Sales in Volume for the Year 2017-2028
1.4 Atrial Fibrillation Devices Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Atrial Fibrillation Devices in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Atrial Fibrillation Devices Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Atrial Fibrillation Devices Market Dynamics
1.5.1 Atrial Fibrillation Devices Industry Trends
1.5.2 Atrial Fibrillation Devices Market Drivers
1.5.3 Atrial Fibrillation Devices Market Challenges
1.5.4 Atrial Fibrillation Devices Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Atrial Fibrillation Devices Market Segment by Type
2.1.1 Catheter Ablation
2.1.2 Maze Surgery
2.2 Global Atrial Fibrillation Devices Market Size by Type
2.2.1 Global Atrial Fibrillation Devices Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Atrial Fibrillation Devices Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Atrial Fibrillation Devices Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Atrial Fibrillation Devices Market Size by Type
2.3.1 United States Atrial Fibrillation Devices Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Atrial Fibrillation Devices Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Atrial Fibrillation Devices Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Atrial Fibrillation Devices Market Segment by Application
3.1.1 Hospitals
3.1.2 Ambulatory Surgical Centers
3.1.3 Others
3.2 Global Atrial Fibrillation Devices Market Size by Application
3.2.1 Global Atrial Fibrillation Devices Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Atrial Fibrillation Devices Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Atrial Fibrillation Devices Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Atrial Fibrillation Devices Market Size by Application
3.3.1 United States Atrial Fibrillation Devices Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Atrial Fibrillation Devices Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Atrial Fibrillation Devices Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Atrial Fibrillation Devices Competitor Landscape by Company
4.1 Global Atrial Fibrillation Devices Market Size by Company
4.1.1 Top Global Atrial Fibrillation Devices Manufacturers Ranked by Revenue (2021)
4.1.2 Global Atrial Fibrillation Devices Revenue by Manufacturer (2017-2022)
4.1.3 Global Atrial Fibrillation Devices Sales by Manufacturer (2017-2022)
4.1.4 Global Atrial Fibrillation Devices Price by Manufacturer (2017-2022)
4.2 Global Atrial Fibrillation Devices Concentration Ratio (CR)
4.2.1 Atrial Fibrillation Devices Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Atrial Fibrillation Devices in 2021
4.2.3 Global Atrial Fibrillation Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Atrial Fibrillation Devices Manufacturing Base Distribution, Product Type
4.3.1 Global Atrial Fibrillation Devices Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Atrial Fibrillation Devices Product Type
4.3.3 Date of International Manufacturers Enter into Atrial Fibrillation Devices Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Atrial Fibrillation Devices Market Size by Company
4.5.1 Top Atrial Fibrillation Devices Players in United States, Ranked by Revenue (2021)
4.5.2 United States Atrial Fibrillation Devices Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Atrial Fibrillation Devices Sales by Players (2020, 2021 & 2022)
5 Global Atrial Fibrillation Devices Market Size by Region
5.1 Global Atrial Fibrillation Devices Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Atrial Fibrillation Devices Market Size in Volume by Region (2017-2028)
5.2.1 Global Atrial Fibrillation Devices Sales in Volume by Region: 2017-2022
5.2.2 Global Atrial Fibrillation Devices Sales in Volume Forecast by Region (2023-2028)
5.3 Global Atrial Fibrillation Devices Market Size in Value by Region (2017-2028)
5.3.1 Global Atrial Fibrillation Devices Sales in Value by Region: 2017-2022
5.3.2 Global Atrial Fibrillation Devices Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Atrial Fibrillation Devices Market Size YoY Growth 2017-2028
6.1.2 North America Atrial Fibrillation Devices Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Atrial Fibrillation Devices Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Atrial Fibrillation Devices Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Atrial Fibrillation Devices Market Size YoY Growth 2017-2028
6.3.2 Europe Atrial Fibrillation Devices Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Atrial Fibrillation Devices Market Size YoY Growth 2017-2028
6.4.2 Latin America Atrial Fibrillation Devices Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Atrial Fibrillation Devices Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Atrial Fibrillation Devices Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Johnson & Johnson
7.1.1 Johnson & Johnson Corporation Information
7.1.2 Johnson & Johnson Description and Business Overview
7.1.3 Johnson & Johnson Atrial Fibrillation Devices Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Johnson & Johnson Atrial Fibrillation Devices Products Offered
7.1.5 Johnson & Johnson Recent Development
7.2 Abbott
7.2.1 Abbott Corporation Information
7.2.2 Abbott Description and Business Overview
7.2.3 Abbott Atrial Fibrillation Devices Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Abbott Atrial Fibrillation Devices Products Offered
7.2.5 Abbott Recent Development
7.3 Medtronic
7.3.1 Medtronic Corporation Information
7.3.2 Medtronic Description and Business Overview
7.3.3 Medtronic Atrial Fibrillation Devices Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Medtronic Atrial Fibrillation Devices Products Offered
7.3.5 Medtronic Recent Development
7.4 Japan Lifeline
7.4.1 Japan Lifeline Corporation Information
7.4.2 Japan Lifeline Description and Business Overview
7.4.3 Japan Lifeline Atrial Fibrillation Devices Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Japan Lifeline Atrial Fibrillation Devices Products Offered
7.4.5 Japan Lifeline Recent Development
7.5 Boston Scientific
7.5.1 Boston Scientific Corporation Information
7.5.2 Boston Scientific Description and Business Overview
7.5.3 Boston Scientific Atrial Fibrillation Devices Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Boston Scientific Atrial Fibrillation Devices Products Offered
7.5.5 Boston Scientific Recent Development
7.6 Atricure
7.6.1 Atricure Corporation Information
7.6.2 Atricure Description and Business Overview
7.6.3 Atricure Atrial Fibrillation Devices Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Atricure Atrial Fibrillation Devices Products Offered
7.6.5 Atricure Recent Development
7.7 Biotroik
7.7.1 Biotroik Corporation Information
7.7.2 Biotroik Description and Business Overview
7.7.3 Biotroik Atrial Fibrillation Devices Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Biotroik Atrial Fibrillation Devices Products Offered
7.7.5 Biotroik Recent Development
7.8 OSYPKA
7.8.1 OSYPKA Corporation Information
7.8.2 OSYPKA Description and Business Overview
7.8.3 OSYPKA Atrial Fibrillation Devices Sales, Revenue and Gross Margin (2017-2022)
7.8.4 OSYPKA Atrial Fibrillation Devices Products Offered
7.8.5 OSYPKA Recent Development
7.9 Cardiofocus
7.9.1 Cardiofocus Corporation Information
7.9.2 Cardiofocus Description and Business Overview
7.9.3 Cardiofocus Atrial Fibrillation Devices Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Cardiofocus Atrial Fibrillation Devices Products Offered
7.9.5 Cardiofocus Recent Development
7.10 MicroPort EP MedTech
7.10.1 MicroPort EP MedTech Corporation Information
7.10.2 MicroPort EP MedTech Description and Business Overview
7.10.3 MicroPort EP MedTech Atrial Fibrillation Devices Sales, Revenue and Gross Margin (2017-2022)
7.10.4 MicroPort EP MedTech Atrial Fibrillation Devices Products Offered
7.10.5 MicroPort EP MedTech Recent Development
7.11 Synaptic Medical
7.11.1 Synaptic Medical Corporation Information
7.11.2 Synaptic Medical Description and Business Overview
7.11.3 Synaptic Medical Atrial Fibrillation Devices Sales, Revenue and Gross Margin (2017-2022)
7.11.4 Synaptic Medical Atrial Fibrillation Devices Products Offered
7.11.5 Synaptic Medical Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Atrial Fibrillation Devices Industry Chain Analysis
8.2 Atrial Fibrillation Devices Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Atrial Fibrillation Devices Distributors
8.3 Atrial Fibrillation Devices Production Mode & Process
8.4 Atrial Fibrillation Devices Sales and Marketing
8.4.1 Atrial Fibrillation Devices Sales Channels
8.4.2 Atrial Fibrillation Devices Distributors
8.5 Atrial Fibrillation Devices Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

 

ページTOPに戻る


 

Summary

This report studies the Atrial Fibrillation Devices market. Atrial fibrillation (also called AFib or AF) is a quivering or irregular heartbeat (arrhythmia) that can lead to blood clots, stroke, heart failure and other heart-related complications. Atrial Fibrillation Devices are the devices used for atrial fibrillation therapy, including access, diagnostic, visualization and ablation products to assist physicians in diagnosing and treating various irregular heart rhythms.
Market Analysis and Insights: Global and United States Atrial Fibrillation Devices Market
This report focuses on global and United States Atrial Fibrillation Devices market, also covers the segmentation data of other regions in regional level and county level.
Due to the COVID-19 pandemic, the global Atrial Fibrillation Devices market size is estimated to be worth US$ 3399.4 million in 2022 and is forecast to a readjusted size of US$ 5576.8 million by 2028 with a CAGR of 8.6% during the forecast period 2022-2028. Fully considering the economic change by this health crisis, by Type, Catheter Ablation accounting for % of the Atrial Fibrillation Devices global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While by Application, Hospitals was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.
The leading manufacturers of atrial fibrillation devices include Johnson & Johnson, Boston Scientific, Abbott, Medtronic, Japan Lifeline, and Atricure, with the top three accounting for about 65%.
North America is the largest market with about 35%, followed by Europe with about 30%.
Global Atrial Fibrillation Devices Scope and Market Size
Atrial Fibrillation Devices market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Atrial Fibrillation Devices market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Atrial Fibrillation Devices market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type
Catheter Ablation
Maze Surgery
Segment by Application
Hospitals
Ambulatory Surgical Centers
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Johnson & Johnson
Abbott
Medtronic
Japan Lifeline
Boston Scientific
Atricure
Biotroik
OSYPKA
Cardiofocus
MicroPort EP MedTech
Synaptic Medical



ページTOPに戻る


Table of Contents

1 Study Coverage
1.1 Atrial Fibrillation Devices Product Introduction
1.2 Global Atrial Fibrillation Devices Outlook 2017 VS 2022 VS 2028
1.2.1 Global Atrial Fibrillation Devices Sales in US$ Million for the Year 2017-2028
1.2.2 Global Atrial Fibrillation Devices Sales in Volume for the Year 2017-2028
1.3 United States Atrial Fibrillation Devices Outlook 2017 VS 2022 VS 2028
1.3.1 United States Atrial Fibrillation Devices Sales in US$ Million for the Year 2017-2028
1.3.2 United States Atrial Fibrillation Devices Sales in Volume for the Year 2017-2028
1.4 Atrial Fibrillation Devices Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Atrial Fibrillation Devices in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Atrial Fibrillation Devices Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Atrial Fibrillation Devices Market Dynamics
1.5.1 Atrial Fibrillation Devices Industry Trends
1.5.2 Atrial Fibrillation Devices Market Drivers
1.5.3 Atrial Fibrillation Devices Market Challenges
1.5.4 Atrial Fibrillation Devices Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Atrial Fibrillation Devices Market Segment by Type
2.1.1 Catheter Ablation
2.1.2 Maze Surgery
2.2 Global Atrial Fibrillation Devices Market Size by Type
2.2.1 Global Atrial Fibrillation Devices Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Atrial Fibrillation Devices Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Atrial Fibrillation Devices Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Atrial Fibrillation Devices Market Size by Type
2.3.1 United States Atrial Fibrillation Devices Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Atrial Fibrillation Devices Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Atrial Fibrillation Devices Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Atrial Fibrillation Devices Market Segment by Application
3.1.1 Hospitals
3.1.2 Ambulatory Surgical Centers
3.1.3 Others
3.2 Global Atrial Fibrillation Devices Market Size by Application
3.2.1 Global Atrial Fibrillation Devices Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Atrial Fibrillation Devices Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Atrial Fibrillation Devices Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Atrial Fibrillation Devices Market Size by Application
3.3.1 United States Atrial Fibrillation Devices Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Atrial Fibrillation Devices Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Atrial Fibrillation Devices Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Atrial Fibrillation Devices Competitor Landscape by Company
4.1 Global Atrial Fibrillation Devices Market Size by Company
4.1.1 Top Global Atrial Fibrillation Devices Manufacturers Ranked by Revenue (2021)
4.1.2 Global Atrial Fibrillation Devices Revenue by Manufacturer (2017-2022)
4.1.3 Global Atrial Fibrillation Devices Sales by Manufacturer (2017-2022)
4.1.4 Global Atrial Fibrillation Devices Price by Manufacturer (2017-2022)
4.2 Global Atrial Fibrillation Devices Concentration Ratio (CR)
4.2.1 Atrial Fibrillation Devices Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Atrial Fibrillation Devices in 2021
4.2.3 Global Atrial Fibrillation Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Atrial Fibrillation Devices Manufacturing Base Distribution, Product Type
4.3.1 Global Atrial Fibrillation Devices Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Atrial Fibrillation Devices Product Type
4.3.3 Date of International Manufacturers Enter into Atrial Fibrillation Devices Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Atrial Fibrillation Devices Market Size by Company
4.5.1 Top Atrial Fibrillation Devices Players in United States, Ranked by Revenue (2021)
4.5.2 United States Atrial Fibrillation Devices Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Atrial Fibrillation Devices Sales by Players (2020, 2021 & 2022)
5 Global Atrial Fibrillation Devices Market Size by Region
5.1 Global Atrial Fibrillation Devices Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Atrial Fibrillation Devices Market Size in Volume by Region (2017-2028)
5.2.1 Global Atrial Fibrillation Devices Sales in Volume by Region: 2017-2022
5.2.2 Global Atrial Fibrillation Devices Sales in Volume Forecast by Region (2023-2028)
5.3 Global Atrial Fibrillation Devices Market Size in Value by Region (2017-2028)
5.3.1 Global Atrial Fibrillation Devices Sales in Value by Region: 2017-2022
5.3.2 Global Atrial Fibrillation Devices Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Atrial Fibrillation Devices Market Size YoY Growth 2017-2028
6.1.2 North America Atrial Fibrillation Devices Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Atrial Fibrillation Devices Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Atrial Fibrillation Devices Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Atrial Fibrillation Devices Market Size YoY Growth 2017-2028
6.3.2 Europe Atrial Fibrillation Devices Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Atrial Fibrillation Devices Market Size YoY Growth 2017-2028
6.4.2 Latin America Atrial Fibrillation Devices Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Atrial Fibrillation Devices Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Atrial Fibrillation Devices Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Johnson & Johnson
7.1.1 Johnson & Johnson Corporation Information
7.1.2 Johnson & Johnson Description and Business Overview
7.1.3 Johnson & Johnson Atrial Fibrillation Devices Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Johnson & Johnson Atrial Fibrillation Devices Products Offered
7.1.5 Johnson & Johnson Recent Development
7.2 Abbott
7.2.1 Abbott Corporation Information
7.2.2 Abbott Description and Business Overview
7.2.3 Abbott Atrial Fibrillation Devices Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Abbott Atrial Fibrillation Devices Products Offered
7.2.5 Abbott Recent Development
7.3 Medtronic
7.3.1 Medtronic Corporation Information
7.3.2 Medtronic Description and Business Overview
7.3.3 Medtronic Atrial Fibrillation Devices Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Medtronic Atrial Fibrillation Devices Products Offered
7.3.5 Medtronic Recent Development
7.4 Japan Lifeline
7.4.1 Japan Lifeline Corporation Information
7.4.2 Japan Lifeline Description and Business Overview
7.4.3 Japan Lifeline Atrial Fibrillation Devices Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Japan Lifeline Atrial Fibrillation Devices Products Offered
7.4.5 Japan Lifeline Recent Development
7.5 Boston Scientific
7.5.1 Boston Scientific Corporation Information
7.5.2 Boston Scientific Description and Business Overview
7.5.3 Boston Scientific Atrial Fibrillation Devices Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Boston Scientific Atrial Fibrillation Devices Products Offered
7.5.5 Boston Scientific Recent Development
7.6 Atricure
7.6.1 Atricure Corporation Information
7.6.2 Atricure Description and Business Overview
7.6.3 Atricure Atrial Fibrillation Devices Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Atricure Atrial Fibrillation Devices Products Offered
7.6.5 Atricure Recent Development
7.7 Biotroik
7.7.1 Biotroik Corporation Information
7.7.2 Biotroik Description and Business Overview
7.7.3 Biotroik Atrial Fibrillation Devices Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Biotroik Atrial Fibrillation Devices Products Offered
7.7.5 Biotroik Recent Development
7.8 OSYPKA
7.8.1 OSYPKA Corporation Information
7.8.2 OSYPKA Description and Business Overview
7.8.3 OSYPKA Atrial Fibrillation Devices Sales, Revenue and Gross Margin (2017-2022)
7.8.4 OSYPKA Atrial Fibrillation Devices Products Offered
7.8.5 OSYPKA Recent Development
7.9 Cardiofocus
7.9.1 Cardiofocus Corporation Information
7.9.2 Cardiofocus Description and Business Overview
7.9.3 Cardiofocus Atrial Fibrillation Devices Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Cardiofocus Atrial Fibrillation Devices Products Offered
7.9.5 Cardiofocus Recent Development
7.10 MicroPort EP MedTech
7.10.1 MicroPort EP MedTech Corporation Information
7.10.2 MicroPort EP MedTech Description and Business Overview
7.10.3 MicroPort EP MedTech Atrial Fibrillation Devices Sales, Revenue and Gross Margin (2017-2022)
7.10.4 MicroPort EP MedTech Atrial Fibrillation Devices Products Offered
7.10.5 MicroPort EP MedTech Recent Development
7.11 Synaptic Medical
7.11.1 Synaptic Medical Corporation Information
7.11.2 Synaptic Medical Description and Business Overview
7.11.3 Synaptic Medical Atrial Fibrillation Devices Sales, Revenue and Gross Margin (2017-2022)
7.11.4 Synaptic Medical Atrial Fibrillation Devices Products Offered
7.11.5 Synaptic Medical Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Atrial Fibrillation Devices Industry Chain Analysis
8.2 Atrial Fibrillation Devices Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Atrial Fibrillation Devices Distributors
8.3 Atrial Fibrillation Devices Production Mode & Process
8.4 Atrial Fibrillation Devices Sales and Marketing
8.4.1 Atrial Fibrillation Devices Sales Channels
8.4.2 Atrial Fibrillation Devices Distributors
8.5 Atrial Fibrillation Devices Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野(その他)の最新刊レポート


よくあるご質問


QYResearch社はどのような調査会社ですか?


QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。   QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/10/07 10:29

149.47 円

164.37 円

198.85 円

ページTOPに戻る